Miriam Garcia

Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

PBMC therapy reduces cell death and tissue fibrosis after acute kidney injury by modulating the pattern of monocyte/macrophage survival in tissue.

PBMC therapy reduces cell death and tissue fibrosis after acute kidney injury by modulating the pattern of monocyte/macrophage survival in tissue.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 12, 2024

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

Journal: Influenza and other respiratory viruses
Published: October 09, 2023

The phagocytosis dysfunction in lupus nephritis is related to monocyte/macrophage CPT1a.

The phagocytosis dysfunction in lupus nephritis is related to monocyte/macrophage CPT1a.

Journal: Immunology letters
Published: June 15, 2023

NGAL release from peripheral blood mononuclear cells protects against acute kidney injury and prevents AKI induced fibrosis.

NGAL release from peripheral blood mononuclear cells protects against acute kidney injury and prevents AKI induced fibrosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2022

Mitochondrial Transplantation Enhances Phagocytic Function and Decreases Lipid Accumulation in Foam Cell Macrophages.

Mitochondrial Transplantation Enhances Phagocytic Function and Decreases Lipid Accumulation in Foam Cell Macrophages.

Journal: Biomedicines
Published: December 22, 2021

Infusion of Phagocytic Macrophages Overexpressing CPT1a Ameliorates Kidney Fibrosis in the UUO Model.

Infusion of Phagocytic Macrophages Overexpressing CPT1a Ameliorates Kidney Fibrosis in the UUO Model.

Journal: Cells
Published: April 30, 2021

Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.

Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.

Journal: Revista clinica espanola
Published: April 07, 2016

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.

Journal: Lupus science & medicine
Published: March 03, 2016

Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.

Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology
Published: September 21, 2015

Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain.

Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain.

Journal: Ocular immunology and inflammation
Published: August 15, 2014

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Journal: Rheumatology (Oxford, England)
Published: July 06, 2014

Prednisone in lupus nephritis: how much is enough?

Prednisone in lupus nephritis: how much is enough?

Journal: Autoimmunity reviews
Published: October 20, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026